Kopran Limited KOPRAN

Latest filings

• Routine15 12 Nov, 18:04 · NSE
  Significant increase in volume has been observed in Kopran Limited
• Routine15 6 Nov, 12:31 · BSE
  Newspaper Publication of Financial Result Q2 of FY 2026-27.
• Routine15 3 Nov, 15:03 · NSE
  Investor Presentation
• Results73 3 Nov, 13:40 · BSE
  Unaudited Results for Q2 FY 2026-27
• Results70 3 Nov, 13:37 · BSE
  Unaudited results for second quarter ended September 30,2026
• Board meeting40 26 Oct, 14:49 · BSE
  Kopran Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve Standalone and Consolidated Unaudited ....
• Approval55 22 Oct, 13:01 · BSE
  Medicine Authority European Union (EU)- conducted GMP inspection at Company's Formulation manufacturing facility located at Khopoli is successfully concluded.
• Routine15 12 Oct, 15:19 · BSE
  For the Quarter ended September 30, 2026
• Insider / SAST45 1 Oct, 08:46 · BSE
  The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sarvamangal Mercantile Company Ltd
• Routine15 25 Sept, 12:08 · NSE
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Shown 15 minutes after publication. Real time with Pro.